Citric Acid → HCID 44544416, compound
Reaction equation
[CH2:1]([NH:8][C:9]([N:11]1[CH:16]2[C@H:17]([CH3:41])[N:18]([CH2:30][C:31]3[CH:32]=[CH:33][CH:34]=[C:35]4[C:40]=3[N:39]=[CH:38][CH:37]=[CH:36]4)[C:19](=[O:29])[C@H:20]([CH2:21][C:22]3[CH:27]=[CH:26][C:25]([OH:28])=[CH:24][CH:23]=3)[N:15]2[C:14](=[O:42])[CH2:13][N:12]1[CH3:43])=[O:10])[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1.[P:44](Cl)(Cl)(Cl)=[O:45].[OH2:49].C(O)(=O)CC(CC(O)=O)(C(O)=O)[OH:53]>O1CCCC1>[P:44]([OH:45])([OH:53])([O:28][C:25]1[CH:24]=[CH:23][C:22]([CH2:21][C@@H:20]2[N:15]3[CH:16]([N:11]([C:9](=[O:10])[NH:8][CH2:1][C:2]4[CH:3]=[CH:4][CH:5]=[CH:6][CH:7]=4)[N:12]([CH3:43])[CH2:13][C:14]3=[O:42])[C@H:17]([CH3:41])[N:18]([CH2:30][C:31]3[CH:32]=[CH:33][CH:34]=[C:35]4[C:40]=3[N:39]=[CH:38][CH:37]=[CH:36]4)[C:19]2=[O:29])=[CH:27][CH:26]=1)=[O:49]Participants
6
Reactant 4
Product 1
Reagents, catalysts & solvents 1
Procedure
To the solution of (6S,9S)—N-benzyl-6-(4-hydroxybenzyl)-2,9-dimethyl-4,7-dioxo-8-(quinolin-8-ylmethyl)octahydro-1H-pyrazino[2,1-c][1,2,4]triazine-1-carboxamide (Compound I-5) 325 mg (0.43 mmol) and TEA 179 μl (1.29 mmol) in tetrahydrofuran 6 ml, phosphoryl chloride 200 μl (2.15 mmol) was added at 0° C. and stirred at room temperature for 4 hours. Water was added to the reaction mixture and stirred additional overnight. The reaction mixture was acidified with 10%-citric acid 30 ml and extracted with chloroform 150 ml. The organic phase was dried with magnesium sulfate and filtered. The filtrate was concentrated in vacuo to obtain the title compound 179 mg (60%).
Workup
- stirringstirred additional overnight
- extractionextracted with chloroform 150 ml
- dry with materialThe organic phase was dried with magnesium sulfate
- filtrationfiltered
- concentrationThe filtrate was concentrated in vacuo
Sources & evidence
- ORD record
- ord-32d19e28b5e5460c9e7831f1a21632f9
- Source dataset
- uspto-grants-2015_11
- Patent number
- US09193734B2
Reaction notes
Loading…